Testimonials

Background stories of how others approached and experienced their European Horizon funding trajectory.

Digital, Industry & Space
Research Centre

Prospects 5.0: Flanders Make coordinates research on the adoptation of Industry 5.0 principles

Prospects 5.0: Flanders Make coordinates research on the adoptation of Industry 5.0 principles

Flanders Make coordinates Horizon Europe Cluster 4 project PROSPECTS 5.0 which analyses how Industry 5.0 principles are being adopted across 14 real‑world industrial use cases in multiple sectors and countries. The consortium partners, among which also KU Leuven, UGent and Flemish SME OCTAVE, translate the gained insights into practical guidance and policy-relevant outputs.

 

Read the full article for details 

Published on 9 hours ago

Related testimonials

These testimonials share at least one programme or target audience.

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.